XML 63 R51.htm IDEA: XBRL DOCUMENT v3.24.2
Inventory - Narrative (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Dec. 31, 2023
[1]
Inventory [Line Items]    
Inventories - current $ 100,704 $ 62,972
Inventories-noncurrent 255,268 $ 206,965
Inventory incurred prior to FDA approval $ 34,900  
Minimum    
Inventory [Line Items]    
Period of lower average per unit cost of materials 5 months  
Maximum    
Inventory [Line Items]    
Period of lower average per unit cost of materials 27 months  
[1] The condensed consolidated balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date.